On 30th December 2020, RUA reported that shareholders had approved resolutions regarding the placing along with a strongly oversubscribed Open Offer. RUA now start 2021 with the resources and mandate to accelerate the development of its products, where we anticipate reports of progress during the year. We have slightly increased our R&D and CapEx spend for FY 2022 to reflect this investment and the cash utilization. RUA’s issued share capital now comprises 22,184,797 shares and the increases in ....
18 Jan 2021
Fundraising completed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Fundraising completed
RUA Life Sciences Plc (RUA:LON) | 10.2 -0.1 (-4.7%) | Mkt Cap: 6.36m
- Published:
18 Jan 2021 -
Author:
Hannah Crowe | Andy Smith -
Pages:
4
On 30th December 2020, RUA reported that shareholders had approved resolutions regarding the placing along with a strongly oversubscribed Open Offer. RUA now start 2021 with the resources and mandate to accelerate the development of its products, where we anticipate reports of progress during the year. We have slightly increased our R&D and CapEx spend for FY 2022 to reflect this investment and the cash utilization. RUA’s issued share capital now comprises 22,184,797 shares and the increases in ....